During the past decade, Oncology Hematology Care Inc-Eden Park conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 48 clinical trials were completed, i.e. on average, 111.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 39 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncology Hematology Care Inc-Eden Park" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "Gynecologic Oncology Group" with 6 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Care Inc-Eden Park" #1 collaborator was "National Cancer Institute (NCI)" with 41 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Hematology Care Inc-Eden Park" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Breast Carcinoma" (5 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Stage IIIA Breast Cancer" (4 trials). Many other conditions were trialed in "Oncology Hematology Care Inc-Eden Park" in a lesser frequency.

Most popular intervention types in "Oncology Hematology Care Inc-Eden Park" are "Drug" (68 trials), "Other" (59 trials), "Biological" (25 trials), "Procedure" (15 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Quality-of-Life Assessment" (19 trials), "Carboplatin" (11 trials), "Cisplatin" (10 trials) and "Docetaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Hematology Care Inc-Eden Park" are 61 trials for "All" genders and 16 trials for "Female" genders.

Currently, there are NaN active trials in "Oncology Hematology Care Inc-Eden Park". undefined are not yet recruiting, 8 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Oncology Hematology Care Inc-Eden Park, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Hematology Care Inc-Eden Park, 4 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".